3779 results about "Cyclodextrin" patented technology

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

According to the invention, there is provided a solid pharmaceutical composition formulation for nasal delivery of an opioid antagonist, comprising a pharmacologically-effective amount of an opioid antagonist and a pharmaceutically-acceptable carrier. The compositions are preferably in the form of a powder produced by spray-drying, which are subsequently loaded into single use nasal applicators. Preferred pharmaceutically-acceptable carriers in this regard include disaccharides (e.g. lactose or trehalose) and dextrins (e.g. cyclodextrins or maltodextrins), preferably spray-dried together in combination. Compositions may further comprise an alkyl saccharide, preferably a sucrose ester, such as sucrose monolaurate. The compositions and applicators may be employed in the treatment of opioid overdose in subjects.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

The present disclosure relates to ophthalmic compositions containing solid complexes of active pharmaceutical ingredient and cyclodextrin, to their method of preparation and their uses. The compositions can include an active agent drug / cyclodextrin complex substantially dissolved in an aqueous eye drop vehicle. The ophthalmic composition is generally in the form of a microsuspension including an active agent complex having a diameter of less than about 100 μm.

The invention relates to a mildew-proof silicone sealant with high curing rate and high adhesive strength, and belongs to the technical field of adhesives. The anti-mildew coating is prepared from alpha, omega-dihydroxy polydimethylsiloxane, dimethyl silicone oil, fumed silica, phenoxy resin coated nano calcium carbonate, a modified hydroxypropyl-gamma-cyclodextrin loaded mildew preventive, dibutyltin dilaurate, methyltrimethoxysilane and a curing accelerator. According to the mildew-proof silicone sealant with the high curing rate and the high adhesive strength, the surface drying time is 9-13 minutes, the 24-hour curing depth is 6.3-7.2 mm, the adhesive strength is 3.0-3.6 MPa, the tensile strength is 5.8-6.4 MPa, the shear strength is 3.0-3.9 MPa, the elongation at break is 410-457%, and the mildew-proof grade is 0 grade in 30 days, 60 days, 180 days and 360 days.

The invention belongs to the technical field of medicines, and provides a cassia twig granular preparation as well as a preparation method and a product thereof. The cassia twig granule preparation is prepared from the following components in parts by weight: 35 to 50 parts of cassia twig granule extract dry paste and 50 to 105 parts of auxiliary materials, the auxiliary materials comprise lactose, beta-cyclodextrin and derivatives thereof, and citric acid. According to the invention, beta-cyclodextrin and derivatives thereof are used for replacing dextrin as an auxiliary material in the cassia twig granules, so that the interference problem of dextrin in drug detection is avoided, the formability, solubility and hygroscopicity of the cassia twig granule preparation are ensured, the stability of the preparation is improved, and the comprehensive performance is excellent.

The invention relates to the technical field of environmental materials and water treatment, in particular to a graphene amino silica gel composite adsorbent for heavy metal wastewater treatment and a preparation method thereof.The graphene amino silica gel composite adsorbent is prepared from # imgabs0 nanoparticles, an amino-functionalized silicon dioxide coating layer, carboxylated reduced graphene oxide, a polydopamine modification layer and tetraethyl orthosilicate; the coating is prepared from the following raw materials: 3-aminopropyltriethoxysilane, 3-mercaptopropyltrimethoxysilane, N-((4-vinyl benzyl) amino) diacetic acid, chitosan, beta-cyclodextrin, hexadecyl trimethyl ammonium bromide, polyethylene glycol, L-ascorbic acid, 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide. The composite adsorbent shows excellent adsorption performance on various heavy metal ions, and the adsorption performance is far higher than that of traditional adsorption materials and existing composite adsorbents.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

The invention discloses a biochar-based slow-release fertilizer and a preparation method thereof, and relates to the technical field of fertilizer production, the biochar-based slow-release fertilizer comprises a core, a carrier layer, a biological layer and a protective layer, the core is composed of macroelements, microelements and a nitrification inhibitor; the carrier layer comprises graphene quantum dot modified charcoal, chitosan, glycerol and cyclodextrin grafted starch; the biological layer is prepared from magnetic Fe3O4 and humic acid nanoparticles, alginic acid oligosaccharide and diatomite; the protective layer comprises a polylactic acid-polycaprolactone block copolymer, acetone, calcium lignosulphonate, a dynamic covalent cross-linking agent gelatin, nano cellulose and an anti-blocking agent. Therefore, by adopting the polylactic acid-polycaprolactone (PLA-PCL)-based segmented copolymer and the dynamic covalent network cross-linking agent, the self-repairing property is endowed. The slow-release fertilizer provided by the invention realizes precise regulation and control of the fertilizer efficiency release rate through a multi-level synergistic effect, has the functions of soil remediation and stress resistance, and significantly improves the utilization efficiency of the fertilizer and the crop adaptability.

The invention provides a gamma-cyclodextrin-based metal organic framework composite material as well as preparation and application thereof. The metal organic framework composite material based on gamma-cyclodextrin comprises chitosan, gamma-CD-MOFs (Metal Organic Frameworks) and an active substance. The preparation method comprises the following steps: by taking chitosan as a film material base material, synthesizing gamma-CD-MOFs by utilizing a hydrothermal method, and then loading cinnamyl aldehyde with antibacterial property, 2-methoxycinnamyl aldehyde with ultraviolet light resistance and curcumin with an antioxidant effect into the gamma-CD-MOFs. And finally, mixing with chitosan with better film-forming property, and spraying on glass or the surfaces of fresh fruits. The gamma-CD-MOFs has the characteristic of slowly releasing bioactive substances, is non-toxic and is a material capable of being applied to food packaging.

The invention discloses herbal oil control essence. A component A comprises deionized water and sodium hyaluronate; the component B comprises methylpropanediol, a hyperforin perforatum flower / leaf / stem extract, cyclodextrin and a rehmannia chinensis root extract; the component C is prepared from water, butanediol, amur corktree bark extract, coptis root extract, radix sophorae flavescentis extract, rhus chinensis insect gall extract, cnidium monnieri fruit extract, zanthoxylum bungeanum fruit extract and camphor tree leaf extract; and the component D comprises 1, 2-hexanediol. The preparation method of the herbal oil-control essence comprises the following steps: S1, preparing raw materials; s2, preparing the component A; s3, preparing the component B; s4, preparing a component C; s5, a mixing process; and S6, adding a component D and carrying out post-treatment. The herbal components form a synergistic effect network and act on a skin grease secretion system in a targeted manner, grease secretion is balanced from the source by adjusting the biological activity of sebaceous gland cells, meanwhile, biological signal channels related to skin anti-inflammation, moisturizing and tightening are activated, and the multiple-effect-in-one skin care effect is achieved.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

The invention relates to the technical field of plugging agents, and discloses a viscoelastic polymer type self-assembly plugging agent and a preparation method thereof. The preparation method comprises the following steps: adding acrylamide, butyl acrylate, 2-acrylamide-2-methylpropanesulfonic acid, quaternized cyclodextrin, gamma-glycidyl ether oxypropyl trimethoxy silane modified bentonite, Schiff base styrene, a sodium dodecyl benzene sulfonate emulsifier and octadecyl dimethyl allyl ammonium chloride into a reaction kettle; and adding an azodiisobutyronitrile initiator into the deionized water, uniformly mixing, and reacting for 4-5 hours at 50-65 DEG C to obtain the viscoelastic polymer type self-assembled plugging agent after the reaction is finished. The plugging agent disclosed by the invention has a relatively good plugging effect, and effectively solves the problem that the gel strength is weakened or the gelling is not thorough due to the formation shearing effect in a continuous gel migration process.

The invention belongs to the technical field of polymer biomaterials, and particularly relates to a multi-drive composite dual-response gel system and a preparation method thereof, and the gel system has good adhesion and thermosensitivity and excellent comprehensive performance. The preparation method comprises the following steps: taking a poly (N-isopropylacrylamide)-acrylamide gel solution and a polyvinyl alcohol-cyclodextrin gel solution as a first layer of gel; one or more of a polyvinyl alcohol-bile acid gel solution, a polyethylene glycol-bile acid gel solution, a polyvinyl alcohol-deoxycholic acid gel solution, a polyvinyl alcohol-taurocholic acid gel solution and a polyvinyl alcohol-glycine gel solution is or are used as a second layer of gel. The two gel solutions are mixed together and are intertwined and cross-linked in a physical space, so that the gel has a large-hole structure; and the mixed gel has two response characteristics due to the double gel solutions, and can be applied to wider fields.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

The invention provides a ziconotide nasal-brain delivery preparation which is high in brain targeting, safe and noninvasive and directly enters the brain through nasal administration. The nasal-brain delivery preparation comprises an active component ziconotide and an absorption enhancer, wherein the absorption enhancer is selected from one or more of dodecyl-beta-D-maltoside (DDM), menthol, hydroxypropyl-beta-cyclodextrin (HP-beta-CD), sodium glycocholate (SGC) and related derivatives thereof. The absorption enhancer with a specific type and content and the ziconotide cooperate and act together, so that the ziconotide bypasses a blood brain barrier, enters the brain through a nasal olfactory mucous membrane, forms a medicine storage bank in an olfactory bulb, is slowly released to the brain and keeps a long-term medicine effect, and therefore, a traditional ziconotide intrathecal administration mode is abandoned; the ziconotide nasal-brain administration mode is created, and the ziconotide nasal-brain administration method is a new-generation therapy for pain diseases related to the central nervous system.

The invention provides a mesenchymal stem cell preparation for promoting knee joint repair as well as a preparation method and application thereof, and belongs to the technical field of medicines. The preparation method comprises the following steps: loading transforming growth factor-beta1 and interleukin-6 on chitosan microspheres, then preparing a chitosan-oxidized starch-carboxymethyl-beta-cyclodextrin bracket loaded with sustained release microspheres, loading luteolin and quercetin, carrying out mixed culture with mesenchymal stem cells, adding a traditional Chinese medicine extract, and carrying out freeze-drying to obtain the luteolin-quercetin-modified mesenchymal stem cells. The mesenchymal stem cell preparation for promoting knee joint repair is prepared. The preparation method of the carbon anode plate for fluorine preparation is simple, the generation of polarization of the carbon anode plate is prevented, and the carbon anode plate has the advantages of low porosity, low ash content, high mechanical strength, high volume density, obviously prolonged service life, low resistivity and the like, and has a wide application prospect.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

The invention relates to the technical field of concrete, and discloses durable concrete and a preparation method thereof.The durable concrete is obtained by adding cement, gravel, fly ash, a polycarboxylate superplasticizer, quaternized triazinyl polyurethane, modified cyclodextrin and water into a stirrer and stirring the materials evenly. A quaternary ammonium salt group in the quaternized triazinyl polyurethane can effectively reduce the adsorption of the clay to the water reducing agent, so that the mixing amount of an additive is reduced, and the working performance and durability of the concrete are improved; wherein the triazinyl group has certain chemical stability and corrosion resistance, so that chlorine salt erosion of the concrete in a severe environment is reduced, and the service life of the concrete is prolonged.

Disclosed herein are compositions comprising an NSAID such as meloxicam and / or rizatriptan in combination with a cyclodextrin and / or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.

The invention discloses a cellulose coated diaphragm and a preparation method thereof in the field of lithium ion batteries, the diaphragm comprises alpha-cellulose pulp, a cellulose grafted phenylboronic acid-co-oligomeric ethylene oxide copolymer, a thermal response star zwitterionic polymer and nano aluminum oxide, and an N-methylmorpholine-N-oxide aqueous solution is adopted as a solvent system. The preparation method comprises the following steps: firstly synthesizing a cellulose grafted copolymer with dynamic borate bonds through atom transfer radical polymerization, then preparing a star polymer with thermal response arms and zwitter-ion terminals by taking cyclodextrin as a core, and finally mixing all the components to prepare coating slurry. And the composite diaphragm is prepared through the processes of coating, phase conversion, ultraviolet curing and drying. The diaphragm combines the thermal stability and lyophilic property of cellulose, forms a dynamic self-adaptive interface layer through the synergistic effect of two functional compounds, has the advantages of active safety protection, dendritic crystal inhibition, long cycle life and the like, and remarkably improves the comprehensive performance of the lithium ion battery.

The invention provides a composite pollution repairing agent as well as a preparation method and application thereof, and belongs to the technical field of environmental functional materials. The composite pollution repairing agent comprises biochar, nano zero-valent iron (nZVI) loaded on the biochar, cyclodextrin and heteroatoms, and at least part of the nZVI is wrapped in the cyclodextrin. According to the prepared composite pollution repairing agent, solid waste resource utilization can be effectively achieved, the removal rate of micro-plastics reaches 90% or above, and the removal rate of heavy metal is 100%. The composite pollution repairing agent has excellent performance and good application prospect, provides a feasible solution for micro-plastic and heavy metal composite pollution treatment, and shows remarkable practical application value.

The invention discloses an electrolytic adhesive, an electrolytic cotton adhesive tape and a preparation method of the electrolytic adhesive. The electrolytic cotton adhesive tape comprises the following components in parts by weight: 5-10 parts of 1, 1 '-ferrocene diformyl chloride, 10-15 parts of acrylic acid beta-cyclodextrin ester, 3-8 parts of polyethylene glycol diglycidyl ether, 10-20 parts of ionic liquid, 1.5-3 parts of a cross-linking agent, 10-15 parts of tackifying resin and 0.5-1.5 parts of an initiator, and a polymer matrix comprises an acrylic acid-hydroxypropyl acrylate copolymer and acrylic acid-2-ethylhexyl ester. Comprising an adhesive layer and an adhesive tape base layer, the adhesive layer is prepared from the electrolytic adhesive, and the adhesive tape base layer is prepared from acrylic foam; the obtained electrolytic cotton adhesive tape has high initial adhesion and viscosity strength after power-on and power-off re-adhesion.

The invention relates to the technical field of bactericides, and discloses an oilfield flooding bactericide containing plant bactericidal components and a preparation method thereof. The preparation method comprises the following steps: loading the plant-based traditional Chinese medicine extract and the isothiazolinone-based corrosion inhibitor on the silver-loaded cyclodextrin metal organic framework to prepare an antibacterial agent / silver-loaded cyclodextrin metal organic framework composite material, and mixing the antibacterial agent / silver-loaded cyclodextrin metal organic framework composite material with methyl methacrylate to prepare the antibacterial agent / silver-loaded cyclodextrin metal organic framework composite material. The bactericide obtained by carrying out copolymerization reaction on modified hydroxyquinoline, vinyl quaternary phosphonium salt and methacrylic acid through an in-situ polymerization method can effectively kill and inhibit the breeding of sulfate reducing bacteria and other bacteria in oilfield reinjection water, and has a certain corrosion inhibition effect.